By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MEDITE Cancer Diagnostics, Inc. 

4203 SW 34th Street

Orlando  Florida  32811  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

MEDITEĀ® Group is a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. MEDITE is poised to become a disruptive force from rapid revenue and market share growth resulting from the introduction of major innovative products in the multibillion dollar global histology and cytology cancer detection marketplace. Depending upon the type of cancer, segments within the current target market of approximately $5.8 billion are growing at annual rates between 10 and 30%. MEDITE anticipates significant growth in revenue and earnings over the next years from several growth trajectories.

YEAR FOUNDED:

1998

LEADERSHIP:

CEO: David E. Patterson


Key Statistics


Email: info@medite-group.com
Ownership: Private

Web Site: MEDITE Cancer Diagnostics
Employees:
Symbol: 
 



Industry
Diagnostics






Company News
//-->